We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation

Delisted

AGTC was delisted on the 30th of November, 2022.

46 hedge funds and large institutions have $25.9M invested in Applied Genetic Technologies Corporation in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 12

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

8% less funds holding

Funds holding: 5046 (-4)

16% less capital invested

Capital invested by funds: $30.8M → $25.9M (-$4.9M)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
46
Holders Change
-4
Holders Change %
-8%
% of All Funds
1%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
4
Increased
14
Reduced
12
Closed
6
Calls
$824K
Puts
Net Calls
+$824K
Net Calls Change
+$108K
Name Holding Trade Value Shares
Change
Change in
Stake
Simplex Trading
51
Simplex Trading
Illinois
-$6.47K -1,580 Closed

AGTC Hedge Fund Activity: Q2 2019 in Review

46 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q2 2019, worth a combined $25.9M — down 16% from $30.8M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of AGTC and 4 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 14 added.

The largest buyer was Colony Group, opening a new position worth an estimated $660K. The largest seller was Acadian Asset Management, exiting entirely with an estimated $2.93M sold.

  • 46 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q2 2019, down from 50 in Q1 2019.
  • Funds reported $25.9M of Applied Genetic Technologies Corporation stock for Q2 2019, down 16% quarter-over-quarter.
  • 4 funds opened new Applied Genetic Technologies Corporation positions in Q2 2019 and 6 closed out, a net change of -2 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q2 2019 was Colony Group, an estimated $660K added.
  • The largest Applied Genetic Technologies Corporation seller in Q2 2019 was Acadian Asset Management, an estimated $2.93M sold.

Based on aggregated 13F filings for Q2 2019.